New York State Common Retirement Fund
PDLI

New York State Common Retirement Fund’s PDL BioPharma, Inc. PDLI Stock Holding History

New York State Common Retirement Fund’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-76,400
Closed -$241K – 3313
2020
Q3 		$241K Hold
76,400
– – ﹤0.01% 2561
2020
Q2 		$222K Hold
76,400
– – ﹤0.01% 2592
2020
Q1 		$215K Hold
76,400
– – ﹤0.01% 2431
2019
Q4 		$248K Sell
76,400
-45,000
-37% -$131K ﹤0.01% 2644
2019
Q3 		$262K Hold
121,400
– – ﹤0.01% 2631
2019
Q2 		$381K Hold
121,400
– – ﹤0.01% 2512
2019
Q1 		$452K Hold
121,400
– – ﹤0.01% 2356
2018
Q4 		$352K Sell
121,400
-33,700
-22% -$92.6K ﹤0.01% 2446
2018
Q3 		$408K Sell
155,100
-28,267
-15% -$69.4K ﹤0.01% 2505
2018
Q2 		$429K Hold
183,367
– – ﹤0.01% 2512
2018
Q1 		$539K Hold
183,367
– – ﹤0.01% 2318
2017
Q4 		$502K Buy
183,367
+28,267
+18% +$86.8K ﹤0.01% 2357
2017
Q3 		$526K Hold
155,100
– – ﹤0.01% 2328
2017
Q2 		$383K Sell
155,100
-1
-0% -$2 ﹤0.01% 2540
2017
Q1 		$352K Buy
155,101
+1
+0% +$2 ﹤0.01% 2550
2016
Q4 		$329K Hold
155,100
– – ﹤0.01% 2562
2016
Q3 		$520K Hold
155,100
– – ﹤0.01% 2299
2016
Q2 		$487K Hold
155,100
– – ﹤0.01% 2285
2016
Q1 		$516K Hold
155,100
– – ﹤0.01% 2244
2015
Q4 		$549K Hold
155,100
– – ﹤0.01% 2272
2015
Q3 		$780K Sell
155,100
-224,444
-59% -$1.29M ﹤0.01% 2094
2015
Q2 		$2.44M Sell
379,544
-72,069
-16% -$483K ﹤0.01% 1754
2015
Q1 		$3.18M Sell
451,613
-203,672
-31% -$1.48M ﹤0.01% 1440
2014
Q4 		$5.05M Buy
655,285
+159,785
+32% +$1.26M 0.01% 1193
2014
Q3 		$3.7M Buy
495,500
+351,700
+245% +$3.27M 0.01% 1343
2014
Q2 		$1.39M Buy
+143,800
New +$1.28M ﹤0.01% 1788

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

New York State Common Retirement Fund's PDLI Position: Q4 2020 in Review

New York State Common Retirement Fund sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 76,400 shares — an estimated $241K sold.

New York State Common Retirement Fund first reported a position in PDLI in Q2 2014 and held it in 26 quarters. The position peaked at $5.05M in Q4 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • New York State Common Retirement Fund reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 76,400 PDL BioPharma, Inc. shares in Q4 2020, an estimated $241K.
  • New York State Common Retirement Fund first reported a position in PDL BioPharma, Inc. in Q2 2014 and held it in 26 quarters.
  • New York State Common Retirement Fund's PDL BioPharma, Inc. position peaked at $5.05M in Q4 2014.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on New York State Common Retirement Fund's 13F filing for Q4 2020, filed 8 Feb 2021.